ELIZABETH HUBERT: Open Payments
NPI 1942897574 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$926 in 31 payments from 16 companies in 2025. Trend: 2023 $492 · 2024 $6,575 · 2025 $926
Food & beverage: $886Education: $40
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $135 |
| Syndax Pharmaceuticals, Inc. | 4 | $134 |
| Novartis Pharmaceuticals Corporation | 4 | $119 |
| Celgene Corporation | 3 | $90 |
| PharmaEssentia USA Corporation | 2 | $59 |
| Rigel Pharmaceuticals, Inc. | 2 | $59 |
| SOBI, INC | 2 | $58 |
| Lilly USA, LLC | 2 | $58 |
| TAIHO ONCOLOGY, INC. | 1 | $35 |
| PFIZER INC. | 1 | $33 |
Products named: SCEMBLIX, REBLOZYL, Xospata, BESREMI, TAVALISSE, Vonjo, JAYPIRCA, INQOVI.
Industry payments across TX — which companies pay providers there.
